Zobrazeno 1 - 10 of 465 pro vyhledávání: '"Rashdan S"'
1
Akademický článek
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report.
Autor: Zhang Y; Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: yuanyuan.zhang@utsouthwestern.edu., Iyengar P; Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Montalvo S; Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Westover KD; Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Rashdan S; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Donthireddy K; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Kim J; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Dowell JE; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Drapkin B; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Bhalla S; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Chukwuma C; Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Nadeem U; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Ahn C; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas., Timmerman RD; Departments of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Gerber DE; Division of Hematology-Oncology, Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2025 Jan 01; Vol. 121 (1), pp. 68-74. Date of Electronic Publication: 2024 Aug 13.
Zobrazit plný text záznamu
2
Akademický článek
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data.
Autor: Song B, Wang K, Na S, Yao J, Fattah FJ, von Itzstein MS, Yang DM, Liu J, Xue Y, Liang C, Guo Y, Raman I, Zhu C, Dowell JE, Homsi J, Rashdan S, Yang S, Gwin ME, Hsiehchen D, Gloria-McCutchen Y, Raj P, Bai X, Wang J, Conejo-Garcia J, Xie Y, Gerber DE, Huang J, Wang T
Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.
Zobrazit plný text záznamu
3
Akademický článek
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice.
Autor: von Itzstein MS; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Yang Y; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States., Wang Y; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hsiehchen D; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States., Sheffield TY; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States., Fattah F; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Popat V; School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ahmed M; School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Homsi J; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Dowell JE; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Rashdan S; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Lohrey J; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hammers HJ; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hughes RS; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States., Wang T; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States., Xie Y; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States., Gerber DE; Department of Internal Medicine (Division of Hematology-Oncology), Dallas, TX, United States.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Apr 16; Vol. 15, pp. 1351739. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer.
Autor: Hopson MB; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Rashdan S; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Publikováno v: Frontiers in oncology [Front Oncol] 2024 Mar 27; Vol. 14, pp. 1373388. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Zobrazit plný text záznamu
6
Akademický článek
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors.
Autor: Mundra V; School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States of America., Yang Y; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., von Itzstein MS; Department of Internal Medicine (Division of Hematology-Oncology), University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Fattah F; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Gonugunta AS; School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States of America., Hannan R; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Pop LM; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Zhang Y; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Wang Y; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Sheffield T; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Xie Y; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Dowell JE; Department of Internal Medicine (Division of Hematology-Oncology), University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Homsi J; Department of Internal Medicine (Division of Hematology-Oncology), University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Rashdan S; Department of Internal Medicine (Division of Hematology-Oncology), University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Park J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Li QZ; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Wakeland EK; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Gerber DE; Peter O'Donnell, Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Internal Medicine (Division of Hematology-Oncology), University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. Electronic address: david.gerber@utsouthwestern.edu.
Publikováno v: Translational oncology [Transl Oncol] 2023 Aug; Vol. 34, pp. 101689. Date of Electronic Publication: 2023 Jun 06.
Zobrazit plný text záznamu
7
Akademický článek
The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer.
Autor: Kalra A; Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical School, Dallas, TX, United States., Rashdan S; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Publikováno v: Frontiers in oncology [Front Oncol] 2023 Apr 14; Vol. 13, pp. 1158417. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).
Zobrazit plný text záznamu
8
Akademický článek
Synthesis and Characterization of Biodegradable Poly(vinyl alcohol)-Chitosan/Cellulose Hydrogel Beads for Efficient Removal of Pb(II), Cd(II), Zn(II), and Co(II) from Water.
Autor: Aljar MAA; Department of Chemistry, College of Science, University of Bahrain, Sakhir P.O. Box 32038, Bahrain., Rashdan S; Department of Chemistry, College of Science, University of Bahrain, Sakhir P.O. Box 32038, Bahrain., Almutawah A; Department of Chemistry, College of Science, University of Bahrain, Sakhir P.O. Box 32038, Bahrain., El-Fattah AA; Department of Chemistry, College of Science, University of Bahrain, Sakhir P.O. Box 32038, Bahrain.; Department of Materials Science, Institute of Graduate Studies and Research, Alexandria University, Alexandria 21526, Egypt.
Publikováno v: Gels (Basel, Switzerland) [Gels] 2023 Apr 13; Vol. 9 (4). Date of Electronic Publication: 2023 Apr 13.
Zobrazit plný text záznamu
9
Akademický článek
Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy Era.
Autor: Gonugunta AS; School of Medicine, UT Southwestern Medical Center., Von Itzstein MS; Department of Internal Medicine (Division of Hematology-Oncology), UT Southwestern Medical Center; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center., Hsiehchen D; Department of Internal Medicine (Division of Hematology-Oncology), UT Southwestern Medical Center; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center., Le T; Department of Internal Medicine (Division of Hematology-Oncology), UT Southwestern Medical Center; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center., Rashdan S; Department of Internal Medicine (Division of Hematology-Oncology), UT Southwestern Medical Center; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center., Yang H; Texas Tech University School of Pharmacy., Selby C; Texas Tech University School of Pharmacy., Alvarez C; Texas Tech University School of Pharmacy; Department of Population and Data Sciences, UT Southwestern Medical Center., Gerber DE; Department of Internal Medicine (Division of Hematology-Oncology), UT Southwestern Medical Center; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center; Department of Population and Data Sciences, UT Southwestern Medical Center. Electronic address: dru.gray@utsouthwestern.edu.
Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2023 Jan; Vol. 24 (1), pp. 11-17. Date of Electronic Publication: 2022 Sep 24.
Zobrazit plný text záznamu
10
Akademický článek
Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials.
Autor: Perez M; 1School of Medicine, UT Southwestern Medical Center, Dallas, Texas.; 2Now with Department of Radiology, University of Washington, Seattle, Washington., Murphy CC; 3School of Public Health, University of Texas Health Science Center at Houston, Dallas, Texas; and., Pruitt SL; 4Department of Population and Data Sciences.; 5Harold C. Simmons Comprehensive Cancer Center., Rashdan S; 5Harold C. Simmons Comprehensive Cancer Center.; 6Department of Internal Medicine, and., Rahimi A; 5Harold C. Simmons Comprehensive Cancer Center.; 7Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas., Gerber DE; 4Department of Population and Data Sciences.; 5Harold C. Simmons Comprehensive Cancer Center.; 6Department of Internal Medicine, and.
Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Jul; Vol. 20 (7), pp. 792-799.e4.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje